163 related articles for article (PubMed ID: 6382282)
1. Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.
Weinstein RS; Miller AW; Coon JS
Prog Clin Biol Res; 1984; 153():249-60. PubMed ID: 6382282
[No Abstract] [Full Text] [Related]
2. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
[TBL] [Abstract][Full Text] [Related]
3. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
Kobayashi H
Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
[TBL] [Abstract][Full Text] [Related]
4. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor.
Summers JL; Coon JS; Ward RM; Falor WH; Miller AW; Weinstein RS
Cancer Res; 1983 Feb; 43(2):934-9. PubMed ID: 6848204
[TBL] [Abstract][Full Text] [Related]
5. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
Sasaki K
Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
[TBL] [Abstract][Full Text] [Related]
6. Multiple cell markers in bladder cancer. Principles and clinical applications.
Javadpour N
Urol Clin North Am; 1984 Nov; 11(4):609-16. PubMed ID: 6390912
[TBL] [Abstract][Full Text] [Related]
7. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
Nasu Y; Kumon H; Matsumura Y; Ohmori H
Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
[No Abstract] [Full Text] [Related]
8. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
Yamada T; Fukui I; Yokogawa M; Oshima H
Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
[No Abstract] [Full Text] [Related]
9. [The study on Thomsen-Friedenreich antigen in bladder tumor].
Oda Y
Hinyokika Kiyo; 1985 Mar; 31(3):407-18. PubMed ID: 3895852
[TBL] [Abstract][Full Text] [Related]
10. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression].
Srougi M; Alves VA; Gayotto LC; Arap S
Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591
[No Abstract] [Full Text] [Related]
11. The study on cell surface antigens in epithelial tumor of the upper urinary tract: ABH-isoantigen and Thomsen-Friedenreich antigen.
Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y; Satoh T
Hinyokika Kiyo; 1989 Jun; 35(6):949-54. PubMed ID: 2801395
[TBL] [Abstract][Full Text] [Related]
12. Tumor markers in bladder cancer.
Huben RP
Urology; 1984 Mar; 23(3 Suppl):10-4. PubMed ID: 6367189
[No Abstract] [Full Text] [Related]
13. [Carcinoma in situ of the urinary bladder: clinical experience and preliminary study of Thomsen-Friedenreich antigen].
Sasaki K; Maru A; Sakashita S; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1984 Feb; 75(2):269-77. PubMed ID: 6379252
[No Abstract] [Full Text] [Related]
14. [Different expressions of various epitopes of the Thomsen-Friedenreich antigen in breast cancer cells. Immunohistochemical study with monoclonal antibodies against asialoglycophorin A].
Bein G; Poschmann A; Seitz RC; Böcker W
Verh Dtsch Ges Pathol; 1985; 69():218-21. PubMed ID: 2420088
[No Abstract] [Full Text] [Related]
15. Molecular markers in the diagnosis and prognosis of bladder cancer.
Lange PH; Limas C
Urology; 1984 Apr; 23(4 Suppl):46-54. PubMed ID: 6369720
[No Abstract] [Full Text] [Related]
16. [Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection].
Cuadrado E; Rodríguez-Trinidad A; Blasco E; Torrado J
Arch Esp Urol; 1985; 38(3):291-9. PubMed ID: 3904638
[No Abstract] [Full Text] [Related]
17. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder].
Hammou JC; Fella C; Vacant J
Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793
[No Abstract] [Full Text] [Related]
18. Detection of Tn antigen with Vicia villosa agglutinin in urinary bladder cancer: its relevance to the patient's clinical course.
Nishiyama T; Matsumoto Y; Watanabe H; Fujiwara M; Sato S
J Natl Cancer Inst; 1987 Jun; 78(6):1113-8. PubMed ID: 3295352
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic markers in transitional carcinoma of the bladder].
Blasco E; Gutiérrez-Hoyos A; Garrido C; Arozena F
Arch Esp Urol; 1991; 44(1):47-52. PubMed ID: 2064423
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of an assessment of ABH(0) isoantigens and Thomsen-Friedenreich (TF) antigen expression in patients with urinary bladder tumours.
Dobrowolski ZF; Duś D; Hałasa J; Radzikowski C
Int Urol Nephrol; 1995; 27(4):395-404. PubMed ID: 8586511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
